The role of interleukin-8 in the immunopathogenesis of HIV-1 disease and tuberculosis

Interleukin-8 (IL-8), a member of the C-X-C chemokine subfamily, is an important chemoattractant and cellular activator. This study was conducted to determine the role of IL-8 in the immunopathogenesis of HIV-I disease and tuberculosis. The first section involved determining the effect of infection with HIV-1, Mycobacterium tuberculosis and co-infection with both of these organisms on IL-8 j_ roduction in vivo. This was monitored by the determination of levels of serum or plasma EL-8 and peripheral cell-associated IL-8, assessing peripheral mononuclear (PBMC) and polymorphonuclear (PMN) cell capacity to produce IL-8 spontaneously or in response to various stimuli, and the detection of constitutive IL-8 mKNA expression in purified subsets of mononuclear cells. Results show that whereas there is evidence of detectable levels of cell-associated EL-8 (mKNA and protein) in peripheral cells of healthy individuals, this is largely lost in the disease states studied. Coupled with this was significantly increased circulating levels of EL-8 in serum and plasma found in HIV-1 infected individuals with or without concomitant pulmonary TB. On the other hand, the capacity of PBMC to produce IL-8 spontaneously ex vivo was enhanced in HIV-1 and TB patients and many of the HFV/TB group, but their corresponding capacities to respond to various stimuli was significantly diminished when compared to that of the normal donors. The release of IL-8 from PMN in the presence of an agonist was diminished mainly in individuals with pulmonary TB, which was further exacerbated by the presence of HIV-1 infection. HIV-1-infected individuals have an increased incidence of bacterial infections which could be related to defective functioning of PMN. The second section was aimed at detecting PMN abnormalities in HIV and I-HV/TB patients by monitoring EL-8-induced p-glucuronidase release and PMN chemotaxis in response to IL-8. IL-8-induced (I-glucuronidase release from PMN of normal individuals and TB patients occurred in a dose-dependent manner. In contrast, PMN from HTV-1 infected individuals, whether co-infected with M tuberculosis or not, showed a reciprocal response in that increasing IL-8 concentrations resulted in decreased enzyme release. This reciprocal slope of the IL-8 dose-response curve was altered for the majority of HIV-1 positive individuals tested irrespective of their CD4+ cell counts. In addition, PMN chemotaxis in response to IL-8 was also found to be significantly impaired in a group of HIV-1 infected patients coinfected w ithM tuberculosis when compared to healthy individuals. The third section of the study involved analysing the expression of the PMN cell surface markers, FcyRIII (CD 16), and the two human IL-8 receptors, designated IL -8RA and 1L-8RB. FcyRIII (CD 16) expression on the surface of PMN was significantly reduced in HIV-1 seropositive patients with pulmonary tuberculosis when compared to those individuals with either disease alone or healthy blood donors. A significant reduction in the percentage of PMN expressing IL-8RA and IL-8RB and in their respective fluorescence intensities was found in TB, HIV, and HTV/TB groups when compared to that obtained for the ND group. IL-8RA intensity of fluorescence was significantly decreased in the HTV/TB group when compared to the TB and HIV groups indicating a further down-regulation of IL-8RA expression owing to dual infection. On the other hand, IL-8RB fluorescence intensity was substantially reduced on PMN from patients with pulmonary TB and to a greater degree in those patients co-infected with HIV-1 and M. tuberculosis. Having found a reduction in the expression of both IL-8 receptors on PMN in all the infection groups, cellular events following the binding of IL-8 to IL-8 receptors on PMN isolated from dually infected patients, the group which showed the greatest reduction in IL-8 expression was analysed. Results indicated that the impairment of DL-8-dependent PMN functions such as degranulation and chemotaxis was associated with the reduced expression of IL-8 receptors on these cells. Increased circulating levels of IL-8 in HIV-1 infection and a diminished cellular capacity to produce IL-8 as shown in this study may have important implications for antimicrobial defences and normal immune processes. A dysregulated production of IL-8 in vivo is likely to play a role in the pathogenesis of HIV-1 disease, pulmonary tuberculosis, and dual infections with both organisms. In addition, cellular responses dependent on specific receptor engagement and the subsequent translation of signal transducing events that lead to phagocyte effector functions are clearly impaired in IL-8 receptor deficient phagocytes. Abnormal PMN functioning in HTV-1 infected individuals, as shown here by defective degranulation and chemotactic responses, have important implications in the pathogenesis of HIV-1 infection in terms of their ability to clear secondary microbial infections. Future attempts should be aimed at defining the mechanisms that bring about these changes in order to contribute to a greater understanding of the mechanisms that lead to an enhanced risk of superinfections in immunosuppressed individuals

Traditional Uses, Pharmacological Activities, and Phytochemical Analysis of <i>Diospyros mespiliformis</i> Hochst. ex. A. DC (Ebenaceae): A Review

Diospyros mespiliformis Hochst. ex. A. DC is widely distributed throughout Africa and around the world. It is utilized ethnobotanically to treat fevers, wounds, malaria, diabetes mellitus, and other diseases. This review aims to provide an exhaustive overview of the traditional uses, pharmacology, and phytochemical analysis of D. mespiliformis, with the objective of identifying its therapeutic potential for further research. Scientific resources, including Google Scholar, Science Direct, Web of Science, Pub Med, and Scopus, were used to find pertinent data on D. mespiliformis. Secondary metabolites tentatively identified from this species were primarily terpenoids, naphthoquinones, phenolics, and coumarins. D. mespiliformis has been reported to demonstrate pharmacological activities, including antimicrobial, antiproliferative, antiparasitic, antioxidant, anti-inflammatory, antiviral, anti-hypersensitivity, and antidiabetic properties. The phytochemicals and extracts from D. mespiliformis have been reported to have some pharmacological effects in in vivo studies and were not toxic to the animal models that were utilized. The D. mespiliformis information reported in this review provides researchers with a comprehensive summary of the current research status of this medicinal plant and a guide for further investigation

Metabolomic Profiling of Antioxidant Compounds in Five Vachellia Species

The genus Vachellia, previously known as Acacia, belongs to the family Fabaceae, subfamily Leguminosae, which are flowering plants, commonly known as thorn trees. They are traditionally used medicinally in various countries including South Africa for the treatment of ailments such as fever, sore throat, Tuberculosis, convulsions and as sedatives. The aim of this study was to determine biochemical variations in five Vachellia species and correlate their metabolite profiles to antioxidant activity using a chemometric approach. The antioxidant activity of five Vachellia aqueous-methanolic extracts were analyzed using three methods: 2,2-di-phenyl-1-picrylhydrazyl (DPPH) radical scavenging assay, 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid (ABTS+) analysis and the ferric reducing antioxidant power (FRAP) assay by means of serial dilution and bioautography with the thin-layer chromatography (TLC) method. Amongst the Vachellia extracts tested, V. karroo, V. kosiensis and V. xanthophloea demonstrated the highest DPPH, ABTS+ and FRAP inhibitory activity. The antioxidant activities of DPPH were higher than those obtained by ABTS+, although these values varied among the Vachellia species. Proton nuclear magnetic resonance (1H NMR), coupled with multivariate statistical modeling tools such as principal component analysis (PCA) and orthogonal partial least squares discriminant analysis (OPLS-DA), were performed to profile metabolites responsible for the observed activity. The OPLS-DA categorized the five Vachellia species, separating them into two groups, with V. karroo, V. kosiensis and V. xanthophloea demonstrating significantly higher radical scavenging activity than V. tortilis and V. sieberiana, which clustered together to form another group with lower radical scavenging activity. Annotation of metabolites was carried out using the ultra-high-performance liquid chromatography–quadrupole time-of-flight mass spectrometry (UHPLC-qTOF-MS), and it tentatively identified 23 metabolites of significance, including epigallocatechin (m/z = 305.0659), methyl gallate (m/z = 183.0294) and quercetin (m/z = 301.0358), amongst others. These results elucidated the metabolites that separated the Vachellia species from each other and demonstrated their possible free radical scavenging activities

Low Maternal Viral Loads and Reduced Granulocyte-Macrophage Colony-Stimulating Factor Levels Characterize Exposed, Uninfected Infants Who Develop Protective Human Immunodeficiency Virus Type 1-Specific Responses

Human immunodeficiency virus type 1 (HIV-1)-specific cellular immune responses are elicited in a proportion of infants born to HIV-1-infected mothers and are associated with protection against vertical transmission. To investigate correlates of these HIV-1-specific responses, we examined levels of the immune activation markers neopterin, β(2)-microglobulin (β(2)-m), and soluble l-selectin (sl-selectin); the immunomodulatory and hematopoietic factors interleukin-7 (IL-7), stromal-cell-derived factor 1 alpha (CXCL12), and granulocyte-macrophage colony-stimulating factor (GM-CSF); and the immunoregulatory cytokine IL-10 among a group of newborns born to HIV-1-positive mothers who did not receive any antiretroviral drugs for prevention of perinatal HIV-1 transmission. Cellular immune responses to HIV-1 envelope (Env) peptides were also measured. We aimed to determine whether newborns who elicit HIV-1-specific cellular immune responses (Env(+)) and those who lack these responses (Env(−)) exhibit unique immune features. Our data confirmed that no Env(+) infants acquired HIV-1 infection. Among exposed, uninfected infants, Env(+) infants had reduced immune activation (as measured by β(2)-m and sl-selectin levels in cord blood plasma) compared to Env(−) infants as well as reduced GM-CSF levels in cord blood plasma. There was also a reduced ability of cord blood mononuclear cells to be induced to produce GM-CSF among Env(+) infants. Maternal viral load was lower in Env(+) infants, suggesting that exposure to low levels of antigen may be responsible for priming the protective responses. These findings suggest that infants who are able to develop apparently protective HIV-1-specific cellular immune responses have immunological features and viral exposure histories that distinguish them from their nonresponder counterparts, providing new insights into the development of HIV-1 protective immunity

Gamma Interferon Production in Response to Mycobacterium bovis BCG and Mycobacterium tuberculosis Antigens in Infants Born to Human Immunodeficiency Virus-Infected Mothers

In utero sensitization to infectious pathogens can establish immunological memory and may influence the immune response to unrelated antigens. Little is known about the influence of intrauterine human immunodeficiency virus (HIV) exposure on the cellular immune response to mycobacterial antigens. Whole-blood culture gamma interferon (IFN-γ) production in response to mycobacterial antigens was measured at birth and 6 weeks of age to determine the characteristics of the IFN-γ response in HIV-exposed infants to Mycobacterium bovis BCG and mycobacterial antigens. At birth, we observed an increased immune activation in response to phytohemagglutinin among HIV-exposed, uninfected infants. In a proportion of these infants, we also observed an increased immune activation in response to purified protein derivative, BCG, and early secreted antigen target 6. Increases in the IFN-γ response to the four antigens between birth and 6 weeks of age, observed in all HIV-unexposed infants, was absent in a substantial proportion of HIV-exposed, uninfected infants. The immunological differences persisted at 6 weeks of age, suggesting a sustained impact of in utero immune priming by HIV. Intrauterine exposure to HIV affects the infants' cellular immune response to mycobacterial antigens, either specifically or as a consequence of nonspecific, broadly reactive immune activation. Further studies will be important to help determine optimal vaccination and disease prevention strategies for this vulnerable population group